Market Place
Sourcing Support
Genocea Closes Shop, Delists From NASDAQ
25 May 2022 //
BENZINGA
Genocea to cut 65% staff; Plans Strategic Alternatives
30 Apr 2022 //
YAHOO FINANCE
Genocea Presents Encouraging Initial Data from GEN-011 Phase 1/2a Trial at AACR
08 Apr 2022 //
GLOBENEWSWIRE
Genocea Biosciences to Host Investor Webinar
04 Apr 2022 //
GLOBENEWSWIRE
Genocea to Present at the 32nd Annual Oppenheimer Healthcare Conference
14 Mar 2022 //
GLOBENEWSWIRE
Genocea Provides Q4 2021 Corporate Update
10 Mar 2022 //
GLOBENEWSWIRE
Genocea to Present and PC Data at AACR
08 Mar 2022 //
GLOBENEWSWIRE
Genocea to Present at the 11th Annual SVB Leerink Global Healthcare Conference
10 Feb 2022 //
GLOBENEWSWIRE
Genocea Provides Second Quarter 2021 Corporate Update
29 Jul 2021 //
GLOBENEWSWIRE
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
22 Jul 2021 //
GLOBENEWSWIRE
Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast
22 Jul 2021 //
GLOBENEWSWIRE
Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011
13 Jul 2021 //
GLOBENEWSWIRE
Genocea Announces Publication in Cancer Discovery Highlighting the Advantages
28 Jan 2021 //
GLOBENEWSWIRE
Genocea Presents Positive GEN-009 Clinical Results, Update on GEN-011 Program
09 Nov 2020 //
GLOBENEWSWIRE
Genocea to Host Investor Call Highlighting New GEN-009 Clinical & Immunogenicity
05 Nov 2020 //
GLOBENEWSWIRE
Genocea Provides Third Quarter 2020 Corporate Update
29 Oct 2020 //
GLOBENEWSWIRE
Genocea Announces Upcoming Data Presentations at Virtual SITC 2020
14 Oct 2020 //
GLOBENEWSWIRE
Genocea Announces FDA Acceptance of GEN-011 IND Application
22 Sep 2020 //
GLOBENEWSWIRE
Genocea to Present at the ESMO Virtual Congress and Two Investor Conf in Sep
04 Sep 2020 //
GLOBENEWSWIRE
GENOCEA TO PRESENT POSITIVE PRELIMINARY CLINICAL DATA EVALUATING NEOANTIGEN
30 Jul 2020 //
PRESS RELEASE
Genocea Announces Private Placement Financing of Up to $80 Million
22 Jul 2020 //
GLOBENEWSWIRE
Genocea Presents Updated Long-term Safety, Immunogenicity & Data from GEN-009
29 May 2020 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.